Company profile for Carisma Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Carisma Therapeutics is pioneering the development of CAR macrophages, a disruptive approach to immunotherapy. Our technology leverages advances in macrophage biology, chimeric antigen receptor engineering and adoptive cellular therapy for the treatment of human disease. Our unique therapeutic approach uses CAR technology to endow human macrophages with the ability to recognize specific targets and triggers macrophage phagocyt...
Carisma Therapeutics is pioneering the development of CAR macrophages, a disruptive approach to immunotherapy. Our technology leverages advances in macrophage biology, chimeric antigen receptor engineering and adoptive cellular therapy for the treatment of human disease. Our unique therapeutic approach uses CAR technology to endow human macrophages with the ability to recognize specific targets and triggers macrophage phagocytic and antigen-presenting functions to attack cancer.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
3675 Market Street, Ste 200 Philadelphia, PA 19104
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercebiotech.com/biotech/carismas-lifeline-dissipates-reverse-merger-plans-fall-through-moderna-cuts-ties

FIERCE BIOTECH
18 Sep 2025

https://www.globenewswire.com/news-release/2025/08/01/3125757/0/en/Ocugen-Provides-Business-Update-with-Second-Quarter-2025-Financial-Results.html

GLOBENEWSWIRE
01 Aug 2025

https://www.globenewswire.com/news-release/2025/06/23/3103287/0/en/Carisma-Therapeutics-and-OrthoCellix-Enter-into-Definitive-Merger-Agreement-to-Create-Company-Focused-on-Regenerative-Cell-Therapies-for-Orthopedic-Diseases.html

GLOBENEWSWIRE
23 Jun 2025

https://www.biospace.com/business/carisma-lays-off-most-of-staff-eyes-sale-of-assets-and-company

BIOSPACE
01 Apr 2025

https://www.prnewswire.com/news-releases/carisma-therapeutics-provides-corporate-updates-302416072.html

PR NEWSWIRE
31 Mar 2025

https://www.fiercebiotech.com/biotech/carisma-axes-sole-clinical-cell-therapy-candidate-lays-23-workers

FIERCE BIOTECH
09 Dec 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty